superoxide dismutase/inflammation

BACKGROUND OF THE INVENTION The present invention relates generally to the field of administration of superoxide dismutase (SOD) to reduce ischemic injury or injury following sepsis or inflammation. In particular, this invention relates to a method and compositions for reducing toxic side effects

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a gene sequence of superoxide dismutase of Aquifex pyrophilus and protein expressed in Escherichia coli. 2. Description of the Prior Art Recently, there has been a variety of attempts to isolate enzymes from the

BACKGROUND OF THE INVENTION 1. FIELD OF THE INVENTION This invention relates to superoxide dismutase derivatives, a method of producing the same and medicinal use of the same. 2. DESCRIPTION OF THE PRIOR ARTS Superoxide dismutase (hereinafter abbreviated as SOD) has been known so far as an enzyme

SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted via EFS-Web and is hereby incorporated by reference in its entirety. The ASCII copy, created on Aug. 8, 2013, is named 41861-702.201_SL.txt and is 3,120 bytes in size. BACKGROUND OF THE INVENTION Peptide

TECHNICAL FIELD The present invention relates to the treatment of wounds in animals in general, and more specifically, to the use of a peptide having human superoxide dismutase activity, glycyl-L-hystidyl-L-lysine: copper(II), for enhancing the wound-healing process. BACKGROUND ART Mechanisms of

BACKGROUND OF THE INVENTION Adverse skin reactions caused by chemical irritants are common among humans. Many of these irritants are constituents of cosmetic products while others are noxious industrial chemicals including organic solvents and caustic materials. In view of this wide spectrum of

BACKGROUND OF THE INVENTION Adverse skin reactions caused by chemical irritants common among humans. Many of these irritants are constituents of cosmetic products while others are noxious industrial chemicals including organic solvents and caustic materials. In view of this wide spectrum of

BACKGROUND OF THE INVENTION The present invention relates to biomaterials modified with non-proteinaceous catalysts for the dismutation of superoxide, and processes for making such materials. This modification may be by covalent conjugation, copolymerization, or admixture of the non-proteinaceous

FIELD OF THE INVENTION The invention relates to novel transcriptional regulatory elements derived from manganese superoxide dismutase (MnSOD) genes, as well as methods of identifying and using the regulatory elements to control gene expression. BACKGROUND OF THE INVENTION Precise control of

This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides. More particularly, the polypeptide of the present invention is Superoxide

This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides. More particularly, the polypeptide of the present invention is Superoxide

This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides. More particularly, the polypeptide of the present invention is Superoxide

FIELD OF THE INVENTION This invention concerns a topical antioxidant composition for the protection and treatment of human skin, particularly skin that is exposed to harmful ultraviolet radiation. BACKGROUND OF THE INVENTION The ultraviolet (UV) wavelengths of sunlight can cause sunburn (erythema)

FIELD OF THE INVENTION This invention concerns a topical antioxidant composition for the protection and treatment of human skin, particularly skin that is exposed to harmful ultraviolet radiation. BACKGROUND OF THE INVENTION The ultraviolet (UV) wavelengths of sunlight can cause sunburn (erythema)

FIELD OF THE INVENTION This invention concerns a topical antioxidant composition for the protection and treatment of human skin, particularly skin that is exposed to harmful ultraviolet radiation. BACKGROUND OF THE INVENTION The ultraviolet (UV) wavelengths of sunlight can cause sunburn (erythema)